303 related articles for article (PubMed ID: 8940636)
21. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
Liu F; Nishikawa M; Clemens PR; Huang L
Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
[TBL] [Abstract][Full Text] [Related]
22. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
23. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
24. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.
Haecker SE; Stedman HH; Balice-Gordon RJ; Smith DB; Greelish JP; Mitchell MA; Wells A; Sweeney HL; Wilson JM
Hum Gene Ther; 1996 Oct; 7(15):1907-14. PubMed ID: 8894682
[TBL] [Abstract][Full Text] [Related]
25. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
26. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene.
Vincent N; Ragot T; Gilgenkrantz H; Couton D; Chafey P; Grégoire A; Briand P; Kaplan JC; Kahn A; Perricaudet M
Nat Genet; 1993 Oct; 5(2):130-4. PubMed ID: 8252038
[TBL] [Abstract][Full Text] [Related]
27. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
Karpati G; Acsadi G
Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
[TBL] [Abstract][Full Text] [Related]
28. Persistence in muscle of an adenoviral vector that lacks all viral genes.
Chen HH; Mack LM; Kelly R; Ontell M; Kochanek S; Clemens PR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1645-50. PubMed ID: 9050832
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.
Molnar MJ; Gilbert R; Lu Y; Liu AB; Guo A; Larochelle N; Orlopp K; Lochmuller H; Petrof BJ; Nalbantoglu J; Karpati G
Mol Ther; 2004 Sep; 10(3):447-55. PubMed ID: 15336645
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated transfer of a human dystrophin gene to skeletal muscle of mdx mouse.
Ragot T; Stratford-Perricaudet LD; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Briand P; Kaplan JC; Kahn A
Gene Ther; 1994; 1 Suppl 1():S53-4. PubMed ID: 8542399
[TBL] [Abstract][Full Text] [Related]
31. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability.
Decrouy A; Renaud JM; Davis HL; Lunde JA; Dickson G; Jasmin BJ
Gene Ther; 1997 May; 4(5):401-8. PubMed ID: 9274716
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
33. Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery.
Clemens PR; Krause TL; Chan S; Korb KE; Graham FL; Caskey CT
Hum Gene Ther; 1995 Nov; 6(11):1477-85. PubMed ID: 8573620
[TBL] [Abstract][Full Text] [Related]
34. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
35. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
[TBL] [Abstract][Full Text] [Related]
36. Progress toward gene therapy of Duchenne muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Semin Neurol; 1999; 19(3):323-32. PubMed ID: 12194388
[TBL] [Abstract][Full Text] [Related]
37. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
Dudley RW; Lu Y; Gilbert R; Matecki S; Nalbantoglu J; Petrof BJ; Karpati G
Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells.
Kimura S; Ikezawa M; Cao B; Kanda Y; Pruchnic R; Cummins J; Huard J; Miike T; Suzuki S
J Gene Med; 2004 Feb; 6(2):155-65. PubMed ID: 14978769
[TBL] [Abstract][Full Text] [Related]
40. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
